Holen Sie sich die Stockscreener-App
0.8796
4.00%
0.0229
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.00%
0.174
|
0.174 | 0.1839 | 0.084 | 0.084 |
| Cost Of Revenue |
-
|
- | 0.00272 | - | - |
| Gross Profit |
0.00%
0.174
|
0.174 | 0.1812 | 0.084 | 0.084 |
Operating Expenses
|
34.17%
3.9244
|
2.925 | 2.8719 | 2.2871 | 1.8269 |
| Benefits Costs and Expenses |
37.14%
3.9646
|
2.891 | 2.8906 | 2.2706 | 1.8683 |
| Costs And Expenses |
37.14%
3.9646
|
2.891 | 2.8906 | 2.2706 | 1.8683 |
| Depreciation and Amortization |
1,259%
0.031
|
0.00228 | 0.0332 | 0.0164 | 0.0151 |
| Operating Income/Loss |
36.33%
-3.7504
|
-2.751 | -2.6907 | -2.2031 | -1.7429 |
| Nonoperating Income/Loss |
218.05%
-0.0402
|
0.034 | -0.0159 | - | - |
| Income/Loss From Continuing Operations Before Tax |
39.52%
-3.7906
|
-2.717 | -2.7066 | -2.1866 | -1.7843 |
| Income/Loss From Continuing Operations After Tax |
39.52%
-3.7906
|
-2.717 | -2.7066 | -2.1866 | -1.7843 |
|
Net Income/Loss
|
39.52%
-3.7906
|
-2.717 | -2.7066 | -2.1866 | -1.7843 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
59.73%
-0.00151
|
-0.00376 | -0.00293 | -0.00178 | -0.00262 |
| Diluted Average Shares |
4.49%
18.30
|
17.51 | 16.67 | - | - |
| Diluted Earnings Per Share |
40.00%
-0.21
|
-0.15 | -0.16 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):